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The Gr,,r activator protein is a glycolipid-binding protein required for the lysosomal degradation of ganglioside Gi,,r. A 
human fibroblast cDNA library was screened with mixtures of oligonucleotide probes corresponding to four different 
areas of the amino acid sequence. A putative clone (821 bp) which gave positive signals to all four probe mixtures was 
purified and sequenced. The sequence was colinear with the sequence of 160 amino acids of the mature GMZ activator 
protein. Availability of the cDNA clone should facilitate investigation into function of the GM* activator protein and 
also into genetic abnormalities underlying GM2 gangliosidosis AB variant. 
GM2 activator protein; GM2 gangliosidosis; cDNA sequence 
1. INTRODUCTION 
Hydrolysis of ganglioside GMZ requires GMM? ac- 
tivator protein in addition to the lysosomal @- 
hexosaminidase A, which consists of two subunits, 
CY and ,&. Inherited defects in any of the three pro- 
tein components in the system, &hexosaminidase 
LY- and &subunits and the Gh12 activator protein 
thus cause a GMMZ gangliosidosis [I]. GMZ 
gangliosidosis due to defective GMM~ activator pro- 
tein but with normal &hexosaminidase subunits is 
known as AB variant [I]. cDNA and genomic 
clones of both of the ,&hexosaminidase have been 
isolated and characterized, and a dozen genetic ab- 
normalities causing the disease have already been 
identified. However, GMZ activator protein has not 
been cloned. In this report we describe isolation of 
a cDNA clone that encodes the mature normal 
human GMZ activator protein. 
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2. MATERIALS AND METHODS 
An SV40-transformed human fibroblast cDNA library in the 
Okayama-Berg vector [2] was kindly supplied by Dr H. 
Okayama. Restriction enzymes and Ml3 vector were purchased 
from Pharmacia and Boehringer Mannheim. The sequencing 
kit and T4 polynucleotide kinase were from Pharmacia. 
[y-“P]ATP (5000 Ci/nmol) and [cu-?S]dATP (1000 Ci/nmol) 
were from Amersham Buchler. Nitrocellulose membranes (type 
HATF) were from Millipore; zeta bind nylon membranes were 
from BioRad Labs. 
2.1. Oligonucleotide mixtures 
Mixtures of oligonucleotide probes corresponding to amino 
acid sequences of four different regions of the mature human 
GMZ activator protein [3,4] were synthesized (table 1). They 
were analyzed by electrophoresis in 20% polyacrylamide/‘l M 
urea gel. The area of the gel containing the oligonucleotide 
band was cut and DNA eluted overnight. The probes were 
labelled at the 5 ‘-end with [y-3ZP]ATP (5000 Ci/nmol) and T4 
polynucleotide kinase [5]. 
2.2. cDNA library screening 
The pcD human fibroblast cDNA library [2] was plated at a 
density of approximately 4000 colonies1134 mm Petri dish. A 
total of 2 x lo5 clones were screened with the oligonucleotide 
mixture no.3 as the probe (table 1). Positive clones were iden- 
tified and purified by repeated screening (51. Prehybridization 
(6 x SSPE, 10 x Denhardt’s solution, 0.5% SDS) and 
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hybridization (6 x SSPE, 5 x Denhardt’s solution, 0.5% SDS, 
50 pmol of 32P-labelled oligonucleotides) were performed in 
plastic pouches with 10 filters/bag at 8°C below the lowest T,,, 
for the probe mixture. Filters were washed at the lowest T,,, for 
the oligonucleotide probe mixture in 6 x SSC, 0.1% SDS for 
3-4 h. 
2.3. DNA sequencing 
The cDNA insert of the purified clone was subcloned into the 
Ml3 vector and sequenced by the dideoxy chain termination 
method [6] with [cu-“S]dATP (1000 Ci/nmol) [7]. The sequence 
analysis was done independently in the two laboratories and 
both strands were used as templates throughout. 
3. RESULTS AND DISCUSSION 
The screening of 2 x lo5 independent clones 
with the oligonucleotide mixture 3 (table 1) initially 
yielded 75 positive clones. Sixty clones were left 
after the second round of screening. They were 
characterized by restriction analysis, agarose gel 
electrophoresis and Southern blotting analysis. 
One clone (pGAP1) was obtained which was 
821 bp long and hybridized to all of the four 
oligonucleotide probe mixtures. 
The sequence of pGAP1 (fig.1) included a seg- 
ment that was colinear with the amino acid se- 
quence of the mature GMMZ activator protein as 
determined by Edman analysis. Ser’* is the N- 
terminal amino acid of the mature GMVIZ activator 
protein. The cDNA sequence included 17 addi- 
tional amino acids on the N,terminal side without 
reaching the initiation codon. Thus, we are unable 
to determine how large the precursor polypeptide 
is. On the other hand, the stop codon is present ex- 
actly at the location predicted from the amino acid 
sequence analysis. Three discrepancies were found 
between the sequences deduced from the 
nucleotide sequences and that determined by Ed- 
man analysis; Vals5 was where Edman analysis ex- 
pected a methionine, and the last two amino acids, 
Gly”* and Ile179, were found instead of 
methionine and serine as predicted by Edman 
analysis. One putative N-glycosylation site is pre- 
sent, Asn-Val-Thr (49-51), in agreement with the 
Edman analysis. Neither a poly(A)+ tail nor a 
polyadenylation signal was present in the 
3 ’ -untranslated region, indicating that the mRNA 
is also longer on the 3 ‘-side than pGAP1. 
pGAP1 does not represent the full-length 
mRNA. The mRNA coding for the GM~ activator 
protein must be longer in both 5 ’ - and 
3 ‘-directions. Attempts are under way to obtain 
full-length cDNA clones for definitive charac- 
terization. Nevertheless, pGAP1 includes the en- 
tire coding sequence of the mature normal human 
GMZ activator protein and thus is useful for 
analysis of the genomic structure and analysis of 
specimens from patients with GMZ gangliosidosis 
AB variant [S]. 
Table 1 
Peptide sequences of GM* activator protein and corresponding oligonucleotide probe 
mixtures 
Oligonucleotide Sequence 
Oligo 1 
(20-mer; 32 mix) 
Oligo 2 
(20-mer; 64 mix) 
Oligo 3 
(23-mer; 256 mix) 
Oligo 4 
(17-mer; 144 mix) 
w 
TGG 
F 
TTT 
C 
D N 
GAT AAT 
c c 
E H 
GAA CAT 
G C 
C H c P 
TGT CAT TGT CCN 
c c C 
c I 
TGT ATT 
c c 
A 
C 
TGT 
C 
F 
TTT 
C 
F 
TTT 
C 
K 
AAA 
G 
D E 
GAT GAA 
C G 
C D 
TGT GAT 
c c 
K E 
AAA GAA 
G G 
I A 
ATT GCN 
C 
A 
G 
GG 
V 
GT 
G 
GG 
A 
GC 
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. . . . . . . TTG 
CTTCTCGCGACCCCTGCGCAAGCCCACCTGAAAAAGCCATCCCAGCTCAGTAGCTTTTCC 
LLATPAQAHLKKP SQLSSFS 
TGGGATAACTGTGATGAAGGGAAGGACCCTGCGGTGATCAG~GCCTGACTCTGGAGCCT 
WDNCDEGKDPAVIRSLTLEP 
GACCCCATCGTCGTTCCTGGAAATGTGACCCTCAGTGTCGTGGGCAGCACCAGTGTCCCC 
DPIVVPGNVTLSV&GSTSVP 
CTGAGTTCTCCTCTGAAGGTGGATTTAGTTTTGGAGAAGGC 
LSSPLKVDLVLEKEVAGLWI 
MGATCCCATGCACAGACTACATTGGCAGCTGTACCTTTG~CACTTCTGTGATGTGCTT 
KIPCTDYIGSCTFEHFCDVL 
GACATGTTAATTCCTACTGGGGAGCCCTGCCCAGAGCCCCTGCGTACCTATGGGCTTCCT 
DMLIPTGEPCPEPLRTYGLP 
TGCCACTGTCCCTTCAAAGAGGAACCTACTACTCACTGCCC~GAGCGMTTCGTTGTGCCT 
CHCPFKEGTYSLPKSEFVVP 
GACCTGGAGCTGCCCAGTTGGCTCACCACCGGGAACTACCGCATAGAGAGCGTCCTGAGC 
DLELPSWLTTGNYRIESVLS 
AGCAGTGGGAAGCGTCTGGGCTGCATCAAGATCGCTGCCTGGGCATATAGCAT 
SSGKRLGCIKIAASLKGI* 
GGCATCTGCCACAGCAGAATGGAGCGGTGTGAGGTGTGT 
TTGCCAAGGCCAAACTCCCACTCTCTGCCCCCCTTTAATCCCCTTTCTACAGTGAGTCCA 663 
ACCTAAGGGAGAATGAGTTGGACAGTTCTTGATAGCCCAGGGCATCTGCTGGGCTGACCA 783 
CGTTACTCATCCCCGTTAACATTCTCTCTAAAGAGCCT 821 
63 
21 
123 
41 
183 
61 
243 
81 
303
101 
363 
121 
423 
141 
483 
161 
543 
179 
603 
723 
Fig. 1. Nucleotide and amino acid sequence of pGAP 1. The insert of the clone pGAP 1 was 821 nucleotides long. The sequences which 
are colinear with the amino acid sequence used for oligonucleotide preparation are underlined. Amino acid residues which differ from 
the sequence obtained by protein analysis of the G MZ activator protein are double underlined. 
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